Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Germanium-fortified Yeast on the Serum Lipids and Immune Cell Subset

게르마늄강화효모가 혈청지질 및 면역세포변화에 미치는 영향

  • 이성희 (게란티제약(주) 중앙연구소) ;
  • 오선우 (게란티제약(주) 중앙연구소) ;
  • 노숙령 (중앙대학교 식품영양학과) ;
  • 이복희 (중앙대학교 식품영양학과) ;
  • 이현주 (한경대학교 영양조리과학과) ;
  • 진동규 (순천향대학병원 순환기내과)
  • Published : 2006.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study was established to investigate the effect of germanium-fortified yeasts on the serum lipid composition and immune system of human body. All 50 subjects with the age range of $50{\sim}75$ were entered in this clinical trial for 6 months. The effects were determined by the proliferative responses of immune-mediated cells, T-cell, B-cell and NK-cell during daily supplementation with/without germanium-fortified yeast. The results of hematology and blood chemistry didn't show any significant differences during administration periods. Serum lipid compositions also didn't show any significant differences during administration periods except triglyceride (TG) and VLDL-cholesterol. TG and VLDL-cholesterol levels were increased significantly by the consumption of germanium-fortified yeast (p<0.05). Immune mediated T-celt and NK-cell didn't increased in both control and test group supplemented with germanium fortified yeast, while B-cell increased in the germanium fortified yeast group after 8 week (p<0.05). Also $TNF-{\alpha}$ increased in the group of germanium fortified yeast after 8 week (p<0.05) but not in the control group. From the above results, germanium fortified yeast is expected to be useful on the improvement of the cellular immune response and protection of organs from various chronic diseases.

본 연구는 게르마늄강화효모 (germanium: 3,210 ppm, 400 mg${\times}$3회/day)가 인체의 혈청지질 및 면역세포 변화에 미치는 효과를 평가를 목적으로 $50{\sim}75$세의 남녀 50명을 대상으로 임상실험을 실시하였으며, 게르마늄강화효모 복용 전후에 따른 혈청지질 수준의 변화 및 면역증진 기능평가에 중요한 역할을 하는 NK세포, B세포, T세포 및 항암기능 효과를 지니는 $TNF-{\alpha}$의 생성의 변화를 확인하였다. 대조군과 보충군 모두 보충 전, 4주, 8주 후의 헤모글로빈, 헤마토크릿, 적혈구 지표(red blood cell indices) 및 백혈구 수, 혈소판, 혈당, ALT, AST, ALP, BUN, Cr, TB, TP, Alb, A/G ratio, ${\gamma}-globulin(g/dL)$이 보충에 따른 유의적인 차이는 나타나지 않았다. 총 콜레스테롤, LDL 콜레스테롤 및 HDL 콜레스테롤은 보충 전, 후에 따른 유의적인 차이는 나타나지 않았다. 중성지방의 경우 대조군에서는 보충 전, 후에 따른 유의적인 차이는 나타나지 않았으나, 게르마늄강화효모 보충군에서는 보충 전에 비해 보충 8주 후에는 p<0.05 수준에서 유의적으로 감소하는 것으로 나타났다. B세포의 경우 대조군에서는 보충 전, 후에 따른 유의적인 차이는 나타나지 않았으나, 게르마늄강화효모 보충군에서는 보충 전에 비해 보충 8주 후에는 p<0.05 수준에서 유의적으로 증가하는 것으로 나타났다. $TNF-{\alpha}$의 경우 대조군에서는 보충 전, 후에 따른 유의적인 차이는 나타나지 않았으나, 게르마늄강화효모 보충군에서는 보충 전에 비해 보충 8주 후에는 p<0.05 수준에서 유의적으로 증가하는 것으로 나타났다. 이는 게르마늄강화효모가 인체의 면역증진에 각종 암, 성인병의 예방과 치료, 인체 면역력의 증진 등 건강증진을 위한 새로운 기능성 원료로의 활용이 기대되며, 이에 대한 지속적인 연구가 사료 된다.

Keywords

References

  1. Tao SH, Bolger PM. 1997. Hazard assessment of germanium supplements. Regul Toxicol Pharmacol 25: 211-219 https://doi.org/10.1006/rtph.1997.1098
  2. Nielsen FH. 1996. How should dietary guidance be given for mineral elements with beneficial actions or suspected of being essential. RDA Workshop: New Approaches, Endpoints and Paradigms for RDAs for mineral elements
  3. Schauss AG. 1991. Nephrotoxicity and neurotoxicity in human from organogermanium compounds and germanium dioxide. Biol Trace Elem Res 29: 267-280 https://doi.org/10.1007/BF03032683
  4. Suzuki F, Brutkiewicz RR, Pollard RB. 1985. Importance of T-cells and macrophages in the antitumoractivity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res 5: 479-483
  5. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ashida N. 1985. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, and organic germanium compound. Microbiol Immunol 29: 65-74 https://doi.org/10.1111/j.1348-0421.1985.tb00803.x
  6. Hammett FS, Nowrey JE Jr, Muller JH. 1992. The erythropoietic action of germanium dioxide. J Exp Med 35: 173-180 https://doi.org/10.1084/jem.35.2.173
  7. Nakada Y, Kosaka T, Kuwabara M, Tanaka S, Sato K, Koide F. 1993. Effects of 2-carboxyethylgermanium sesquioxide (Ge-132) as an immunological modifier of postsurgical immunosuppression in dogs. J Vet Med Sci 55: 795-799 https://doi.org/10.1292/jvms.55.795
  8. Sijpesteijn AK, Rijkens F, Van Der Kerk GJ, Manten A. 1964. Antimicrobial activity of organogermanium deriva-tives. Nature 201: 736
  9. Han C, Yin WG, Shen M. 1992. Inhibition by germanium oxide of the mutagenicity of cadmium chloride in various genotoxicity assays. Food Chem Toxicol 30: 521-524 https://doi.org/10.1016/0278-6915(92)90104-S
  10. Lee CH, Lin RH, Liu SH, Lin-Shiau SY. 1998. Effects of germanium oxide and other chemical compounds on phenylmercury acetate-induced genotoxicity in cultured human lymphocytes. Environ Mol Mutagen 31: 157-162 https://doi.org/10.1002/(SICI)1098-2280(1998)31:2<157::AID-EM7>3.0.CO;2-J
  11. Ho CC, Chern YF, Lin MT. 1990. Effect of organogermanium compound 2-carboxyethyl germanium sesquioxide on cardiovascular function and motor activity in rats. Pharmacol 41: 286-291 https://doi.org/10.1159/000138736
  12. Schroeder HA. 1967. Serum cholesterol levels in rats fed thirteen trace elements. J Nutrition 94: 68-71
  13. Anna KK. 1990. Yeasts and yeast-like organisms. 1st ed. VCH Press, New York. p 131-205
  14. Song WJ, Lee SC, Oh TK. 1995. Preparation of organic germanium by yeast cell. Kor J Appl Microbiol Biotechnol 23: 87-90
  15. Lee SH, Ahn SD, Rho SN, Sohn TU. 2005. A study on preparation and binding properties of germanium-fortified yeast. J Korean Soc Appl Biol Chem 48: 382-387
  16. Ono M, Orita K. 1982. Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice. Gan To Kagaku Ryoho 9: 1771-1777
  17. Brenner DE, Jones HW, Rosenshein NB, Forastiere A, Dillon M, Grumbine F, Tipping S, Burnett L, Greco FA, Wiernik PH. 1983. Phase II evaluation of spirogermanium in advanced ovarian carcinoma. Cancer Treat Rep 67: 193-194
  18. Dimartino MJ, Lee JC, Badger AM, Muirhead KA, Mirabelli CK, Hanna N. 1986. Antiarthritics and immunoregulatory activity of spirogermanium. J Pharmacol Exp Ther 236: 103-110
  19. Nielsen FH. 1994. Ultratrace minerals. In Modern nutrition in health and disease. 8th ed. Shils ME, Olson JA, Shike M, eds. Lea & Febiger, Philadelphia, PA. p 269-286
  20. Nielsen FH. 1996. Trace elements. In Present Knowledge in Nutrition. 7th ed. Ziegler EE, Filer LJ Jr, eds. International Life Sciences Institute-Nutrition Foundation, Washington, DC. p 353-377
  21. Joo SS, Won TJ, Lee YJ, Kim MJ, Lee DI, Park SY, Lee SH, Hwang KW. 2006. Effect of Geranti Bio-Ge yeast, a dried yeast containing biogermanium, on the production of antibodies by B cell proliferation. Immune Network 6: 86-92 https://doi.org/10.4110/in.2006.6.2.86
  22. Kim YS. 1990. Classification and assessment of obesity. Korean J Nutr 23: 227-340
  23. Friedewald WT, Levy RL, Fredrickson DS. 1972. Esti-mation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 18: 499-502
  24. Matsusaka T, Fujii M, Nakano T, Terai T, Kurata A, Imaizumi M, Abe H. 1988. Germanium-induced neophropathy: report of two cases and review of the literature. Clinical Nephrology 30: 341-345
  25. Okada K, Okagawa K, Kawakami K, Kuroda Y, Morizumi K, Sato H, Morita H, Shimomura S, Saito S. 1989. Renal failure caused by long-term use of a germanium preparation as an elixir. Clin Nephrol 31: 219-224
  26. Xie W, Chen X, Yang K. 1996. Effects of selenium and germanium on lipid peroxidation in rats fed with low-selenium grain. Chin J Prev Med 30: 113-115
  27. Stephen AL, Parris MK. 1986. Oxygen-nutrition for super health: Research breakthrough on an oxygen catalyst. J Orthomol Med 1: 313-317
  28. Pronai L, Arimori S. 1992. Decreased plasma superoxide scavenging activity in immunological disorders--car-boxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone. Biotherapy 4: 1-8 https://doi.org/10.1007/BF01878115
  29. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. 1985. Induction of interferon and activation of NK cells and marcrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol Immunol 29: 65-74 https://doi.org/10.1111/j.1348-0421.1985.tb00803.x
  30. Lee JS, Park JL, Kim SH, Kang SK, Park CB, Jang JY, Kang JK, Kim YB. 2004. Oral single and repeted dose toxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in rats. J Toxicol Sci 29: 541-553 https://doi.org/10.2131/jts.29.541

Cited by

  1. Nutritional Status and Hair Mineral Content of Elementary School Children with Behavioral Problems vol.18, pp.2, 2012, https://doi.org/10.14373/JKDA.2012.18.2.097
  2. Beneficial Effects of Desalinated Magma Seawater in Ameliorating Thioacetamide-induced Chronic Hepatotoxicity vol.24, pp.1, 2006, https://doi.org/10.1007/s12257-018-0371-9